Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
PLoS ONE - United States
doi 10.1371/journal.pone.0154795
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 3, 2016
Authors
Publisher
Public Library of Science (PLoS)